Results of a randomised phase II study of cisplatin plus 5-fluorouracil versus cisplatin plus 5-fluorouracil with α-interferon in metastatic pancreatic cancer: an EORTC gastrointestinal tract cancer group trial

This publication has 12 references indexed in Scilit:

• No standard treatment is available for advanced pancreatic cancer
  European Journal Of Cancer, 1995
• Pancreatic Cancer: Multimodality treatment of locally advanced pancreatic cancer
  Annals of Oncology, 1994
• Activity of cisplatin in adenocarcinoma of the pancreas
  European Journal Of Cancer, 1993
• Phase II trial with ifosfamide in pancreatic cancer
  European Journal Of Cancer, 1993
• Interferon alpha-2a and 5-fluorouracil for advanced colorectal carcinoma assessment of activity and toxicity
  Cancer, 1990
• Phase II study of fluorouracil and recombinant interferon alfa-2a in previously untreated advanced colorectal carcinoma.
  Journal of Clinical Oncology, 1990
• Original article: Potentiation of cisplatin by alpha-Interferon in advanced non-small cell lung cancer (NSCLC): A phase II study
  Annals of Oncology, 1990
• Augmentation of chemically induced pancreatic and bronchial cancers by epidermal growth factor.
  Gut, 1987
• Enhanced expression of epidermal growth factor receptor correlates with alterations of chromosome 7 in human pancreatic cancer.
  Proceedings of the National Academy of Sciences, 1986
• Autocrine growth factors and cancer
  Nature, 1985